The β2-adrenergic biased agonist nebivolol inhibits the development of Th17 and the response of memory Th17 cells in an NF-κB-dependent manner
Mehri Hajiaghayi(Concordia University), Peter J. Darlington(Concordia University)
Cited by 3
Related Papers
Diminished Th17 (not Th1) responses underlie multiple sclerosis disease abrogation after hematopoietic stem cell transplantation
|Annals of Neurology|2012|152
Reciprocal Th1 and Th17 regulation by mesenchymal stem cells: Implication for multiple sclerosis
|Annals of Neurology|2010|80